| Company Name: |
Guangzhou PI PI Biotech Inc
|
| Tel: |
+86-020-81716320 +86-13602409664 |
| Email: |
Sales@pipitech.com |
| Products Intro: |
Product Name:Lenvatinib N-Oxide
CAS:1788901-86-9
Purity:90%+ Package:10mg, 25mg, 50mg, 100mg, Other scale please email Sales@pipitech.com Remarks:4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide 1-Oxide
|
| Company Name: |
Adamas Reagent, Ltd.
|
| Tel: |
400-6009262 16621234537 |
| Email: |
zhangsn@titansci.com |
| Products Intro: |
Product Name:Lenvatinib N-Oxide
CAS:1788901-86-9
Purity:对照品 Package:10mg~500mg Remarks:AC001360026
|
| Company Name: |
Jiangsu Vcare PharmaTech Co., Ltd.
|
| Tel: |
025-58741518; 18013018875 |
| Email: |
sales@vcarepharmatech.com |
| Products Intro: |
CAS:1788901-86-9
Purity:95% Package:1g Remarks:362-2G
|
| Company Name: |
S.Z. PhyStandard Bio-Tech. Co., Ltd.
|
| Tel: |
0755-4000505016 13380397412 |
| Email: |
3001272453@qq.com |
| Products Intro: |
Product Name:Lenvatinib Impurity 10
CAS:1788901-86-9
Purity:99% HPLC Package:10mg;25mg;50mg;100mg
|
|
| | Lenvatinib Impurity 5 Basic information |
| Product Name: | Lenvatinib Impurity 5 | | Synonyms: | 6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-, 1-oxide;Levatinib impurity 10;Lenvatinib impurity 1 4/Lenvatinib N-Oxide/4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide 1-Oxide;6-carbamoyl-4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline 1-oxide;Lenvatinib Impurity M | | CAS: | 1788901-86-9 | | MF: | C21H19ClN4O5 | | MW: | 442.85 | | EINECS: | | | Product Categories: | | | Mol File: | 1788901-86-9.mol |  |
| | Lenvatinib Impurity 5 Chemical Properties |
| density | 1.54±0.1 g/cm3(Predicted) | | solubility | Methanol (Slightly, Heated) | | pka | 13.10±0.70(Predicted) | | form | Solid | | color | Pale Yellow to Light Yellow |
| | Lenvatinib Impurity 5 Usage And Synthesis |
| Uses | Lenvatinib N-Oxide is a metabolite of Lenvatinib (L329400) which is an orally active inhibitor of multiple receptor tyrosine kinases including VEGF, FGF and SCF receptors. |
| | Lenvatinib Impurity 5 Preparation Products And Raw materials |
|